Century Therapeutics director granted 74,000 stock options
Century Therapeutics director Daphne Quimi received a grant of stock options for 74,000 shares of Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Century Therapeutics director Daphne Quimi received a grant of stock options for 74,000 shares of Common Stock. The options have an exercise price of $2.24 per share, expire on June 11, 2036, and vest on the earlier of June 11, 2027, or the next annual stockholder meeting, subject to continued service. Following this grant, Quimi holds 74,000 stock options directly.
Insider Trade Summary
Grant/Award: 74,000 shares
Grant/Award
1 txn
Insider
Quimi Daphne
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 74,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 74,000 contracts (Direct)
Footnotes (1)
- F1. The option vests on the earlier of (a) June 11, 2027, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date.
Key Figures
Options granted: 74,000 options
Exercise price: $2.24 per share
Underlying shares: 74,000 shares
+3 more
6 metrics
Options granted
74,000 options
Stock Option (right to buy) grant to director
Exercise price
$2.24 per share
Strike price for Common Stock underlying options
Underlying shares
74,000 shares
Common Stock covered by the option grant
Expiration date
June 11, 2036
Option term end date
Vesting date
June 11, 2027 or next annual meeting
Earlier of these dates, subject to continued service
Options held after grant
74,000 options
Total derivative holdings following this transaction
Key Terms
Stock Option (right to buy), exercise price, expiration date, vesting, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: "Stock Option (right to buy)""
exercise price financial
"conversion_or_exercise_price: "2.2400""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-06-11T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"The option vests on the earlier of (a) June 11, 2027, or (b) the next annual meeting of stockholders"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Century Therapeutics (IPSC) report for Daphne Quimi?
Century Therapeutics reported a stock option grant to director Daphne Quimi. She received 74,000 options to purchase Common Stock at $2.24 per share, expiring June 11, 2036, with vesting tied to future service and a specified vesting date or annual meeting.
How many stock options did Daphne Quimi receive from Century Therapeutics (IPSC)?
Daphne Quimi received 74,000 stock options. Each option represents the right to buy one share of Century Therapeutics Common Stock at a fixed exercise price, subject to vesting conditions and an expiration date in 2036 if not exercised earlier.
What is the exercise price of Daphne Quimi’s Century Therapeutics (IPSC) stock options?
The exercise price of Daphne Quimi’s options is $2.24 per share. This is the price she must pay to purchase each share of Common Stock once the options vest, provided she exercises them before the stated expiration date.
When do Daphne Quimi’s Century Therapeutics (IPSC) stock options vest?
The options vest on the earlier of June 11, 2027, or the next annual stockholder meeting. Vesting in either case requires Daphne Quimi to continue serving through the applicable vesting date, aligning the award with ongoing board service.
What is the expiration date of Daphne Quimi’s stock options at Century Therapeutics (IPSC)?
The stock options granted to Daphne Quimi expire on June 11, 2036. If the options are not exercised by that expiration date, the right to buy Century Therapeutics Common Stock at $2.24 per share will lapse and become worthless.
How many Century Therapeutics (IPSC) stock options does Daphne Quimi hold after this grant?
After this grant, Daphne Quimi holds 74,000 stock options directly. The Form 4 indicates that this total reflects her derivative holdings in these options following the reported award, all subject to the vesting schedule and expiration date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
